Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature

Jordan Pilkington; Sara Shalin; Henry K Wong

doi:10.3390/hematolrep16010002

Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature

Hematol Rep. 2023 Dec 28;16(1):11-21. doi: 10.3390/hematolrep16010002.

Authors

Jordan Pilkington¹, Sara Shalin², Henry K Wong^{2

3}

Affiliations

¹ College of Medicine, University of Arkansas for Medical Sciences: 1, Little Rock, AR 72205, USA.
² Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
³ Central Arkansas Veterans Health System, Little Rock, AR 72205, USA.

Abstract

Post-transplant lymphoproliferative disease is a rare disorder with an annual incidence of 0.5% to 3.7%. Development of this disorder carries with it a poor prognosis. In this report, we describe a rare case of post-transplant primary cutaneous T-cell lymphoma (PT-CTCL) mycosis fungoides stage IIB in a patient following kidney transplantation, as well as a review of PT-CTCL reported in the literature. The treatment following diagnosis included bexarotene, cyclosporine, and prednisone. Currently, the patient is free from disease. This information aims to add to the knowledge of the prevalence and management of PT-CTCL.

Keywords: cutaneous T-cell lymphoma; kidney transplant; mycosis fungoides; post-transplant lymphoproliferative disease; transplant.

Publication types

Case Reports

Grants and funding

This research received no external funding.